10-n-nonylacridinium orange has been researched along with gold in 1 studies
Studies (10-n-nonylacridinium orange) | Trials (10-n-nonylacridinium orange) | Recent Studies (post-2010) (10-n-nonylacridinium orange) | Studies (gold) | Trials (gold) | Recent Studies (post-2010) (gold) |
---|---|---|---|---|---|
74 | 1 | 17 | 47,670 | 302 | 31,345 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahijado-Guzmán, R; Almendro-Vedia, VG; Barcina, JO; Ferrer, I; González-Rubio, S; Guerrero-Martínez, A; Junquera, E; López-Montero, I; Manzaneda-González, V; Muñoz-Úbeda, M; Natale, P; Paz-Ares, L; Salgado, C | 1 |
1 other study(ies) available for 10-n-nonylacridinium orange and gold
Article | Year |
---|---|
Tunable gold nanorod/NAO conjugates for selective drug delivery in mitochondria-targeted cancer therapy.
Topics: Acridine Orange; Aminoacridines; Animals; Cetuximab; ErbB Receptors; Fibroblasts; Gold; Humans; Lung Neoplasms; Mice; Mitochondria; Nanotubes | 2022 |